Table 1.
Comparison of general data (x̅ ± sd)
| Case (n) | Dexmedetomidine group (n=45) | Control group (n=45) | t/χ2 | P |
|---|---|---|---|---|
| Types of diseases | ||||
| Uterine fibroids | 19 | 20 | 0.045 | 0.832 |
| Adenomyosis | 16 | 15 | 0.049 | 0.824 |
| Uterine fibroids with adenomyosis | 7 | 6 | 0.089 | 0.764 |
| Refractory dysfunctional uterine bleeding | 3 | 4 | 0.155 | 0.694 |
| ASA I/II | 24/21 | 22/23 | 0.178 | 0.673 |
| Age (years) | 46.5±7.1 | 47.6±8.3 | 0.676 | 0.501 |
| BMI (kg /m2) | 22.83±2.21 | 23.61±2.45 | 1.586 | 0.116 |
| Pneumoperitoneum time (min) | 112.36±10.63 | 109.09±11.31 | 1.413 | 0.161 |
| Amount of bleeding (mL) | 135.32±22.73 | 129.54±20.36 | 1.271 | 0.207 |
| Amount of rehydration (L) | 1.08±0.41 | 1.12±0.39 | 0.474 | 0.637 |
Note: t: data from t-test; χ2: data from Chi-squared test. BMI: body mass index. ASA, American Society of Anesthesiologists.